Malondialdehyde in early phase of acute pancreatitis

Rev Esp Enferm Dig. 2011 Nov;103(11):563-9. doi: 10.4321/s1130-01082011001100002.
[Article in English, Spanish]

Abstract

Aims: to assess oxidative stress in acute pancreatitis, its evolution over time and its relationship with the severity of the disease.

Methods: during a two-year period, patients with acute pancreatitis with less than 24 hours of pain were evaluated. Serum was obtained the first, second and fourth day from admittance, if complications were detected, and after recovery. Malondialdehyde was determined by high performance liquid chromatography. Twenty healthy volunteers constituted the control group. Malondialdehyde between groups was compared with Mann-Whitney and Kruskal-Wallis tests; malondialdehyde evolution was studied with Wilcoxon test.

Results: one hundred and sixty-nine patients were included (91 women, median age 67 years, range 20-95); 33 suffered a severe episode. Malondialdehyde decreased from first to fourth day (0.600 vs. 0.451 vs. 0.343 M, respectively, p < 0.05). When complications were detected, malondialdehyde level was similar to that of first and second day (0.473 M, p > 0.05). In severe attacks malondialdehyde was higher than in control group at day 2 (severe: 0.514; mild: 0.440; control: 0.347 M, p < 0.05 severe vs. control).

Conclusions: an early oxidative stress is observed in acute pancreatitis. In severe attacks, oxidative stress remains high longer than in mild episodes. The onset of complications is associated with high malondialdehyde concentration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Case-Control Studies
  • Chromatography, High Pressure Liquid
  • Disease Progression
  • Female
  • Humans
  • Male
  • Malondialdehyde / blood*
  • Middle Aged
  • Oxidative Stress*
  • Pancreatitis / blood
  • Pancreatitis / physiopathology*
  • Prognosis
  • Prospective Studies
  • Severity of Illness Index

Substances

  • Biomarkers
  • Malondialdehyde